SCHEMBL7269409

SCHEMBL7269409

CC(C)[C@H](N)C(=O)N(C(=O)CCc1ccccn1)C(Cc1ccccc1)C(O)C(Cc1ccccc1)N(C(=O)CCc1ccccn1)C(=O)[C@@H](N)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
CA2 P00918 2/20 0.43
POLB P06746 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PTPRA P18433 1/20 0.39
KMT2A Q03164 1/20 0.38
MAOB P27338 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A4 P08684 1/20 0.37
RAF1 P04049 1/20 0.37
MAP2K1 Q02750 1/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449597 0.99 CYP1A2 (0.44) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7433502 0.87 CYP1A2 (0.38) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7269049 0.83 LMNA (0.47) CYP1A2MAPTCYP2C19CYP3A4KDM4E
SCHEMBL7270433 0.83 TSHR (0.56) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL6447519 0.82 LMNA (0.48) CYP1A2MAPTCYP2C19CYP3A4KDM4E
SCHEMBL9740522 0.82 LMNA (0.48) CYP1A2MAPTCYP2C19CYP3A4KDM4E
SCHEMBL7275895 0.82 PGR (0.47) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL7278089 0.82 CA2 (0.53) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL6447678 0.82 PGR (0.46) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR
SCHEMBL9741338 0.82 CA2 (0.52) CYP1A2SMN1; SMN2CYP2D6MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed